INVEST IN KAZU BY WELLNESS INSIGHT TECHNOLOGIES, INC. TODAY!
Kazu: Health In Tune With You
$13,817.25 Raised
REASONS TO INVEST
Our interactive device and AI-enabled platform work with you to dispense precision doses, provide personalized guidance, and track results, improving your health and wellness outcomes.
We have filed ten patents for our technology, manufactured thousands of first-generation units for study purposes, and created production tooling, positioning us to create a new category at the intersection of the multi-billion dollar health technology, medicine, and supplements markets.
The value we deliver increases over time as platform adoption grows and our AI learns from a growing user base, allowing us to continuously offer new and improved services and products as our technology develops.
the pitch
We at Wellness Insight Technologies developed Kazu, a handheld interactive device that dispenses personalized amounts of medicines and supplements to optimize health and wellness. The Kazu platform includes pods (consumables) and an AI-enabled app. Kazu provides personalized dosing insights, tracks progress, and addresses a myriad of the shortcomings of industrialized medicine. We are initially targeting the millions of self-care consumers who use CBD and melatonin for sleep, stress, relief, and more. Since our launch, we have invested in 5 years of R&D, developed products for pharma companies, filed 10 patents, manufactured thousands of first-generation units, and completed production tooling. The Kazu product is not yet available on the market.
Overview
Enabling Precise Personalization of Health and Wellness
*The above is a rendering of the Kazu product that is not yet available on the market.
Kazu brings the connected-health revolution to a range of markets, including natural medicines, dietary supplements, and over-the-counter (OTC) pharmaceuticals. We funded the R&D process through revenue generated from development agreements with a number of pharmaceutical companies. We have manufactured thousands of first-generation units for third-party study purposes and have completed production tooling for the consumer launch version. With this raise, we will make our software user-friendly, secure inventory, and execute our go-to market strategy.
The Problem & Our solution
Personalized Precision Dosing for Improved Outcomes
Personalized medicine achieves better health outcomes through precise doses that are tailored to each individual, but remains too expensive, inaccessible, and even unavailable for many of the most common issues. Moreover, today's industrialized medicine is based on averages, providing a one-size-fits-all approach that may or may not fit with your unique physiology. The result is that many people either overmedicate and waste money or consume too little of what they need to achieve optimal results.
*The above is a rendering of the Kazu product that is not yet available on the market.
We enable our users to precisely control their own doses with personalized AI-enabled guidance derived from their own unique characteristics. Our platform combines a handheld device with an interactive touchscreen, a variety of pre-filled CBD and melatonin pods, and a Bluetooth-connected mobile app to allow our users to take charge of their own health and wellness.
the market & Our Traction
Proven Technology at the Intersection of Multiple Major Markets
We are creating a new category that intersects health technology, medicine, and supplements. The closest comparison is the wearable medical device market, projected to reach $196 billion by 2027, with a CAGR of 26.4% (Source). Meanwhile, the natural medicine and dietary supplements market is expected to reach $313 billion by 2028. Within this are our launch categories. The CBD category alone is estimated to reach $56 billion in 2028 with a CAGR of 47.5%, and the sleep aid medication category is projected to grow to $33 billion by 2030 (Source | Source).
Source | Source | Source | Source
*The above is a rendering of the Kazu product that is not yet available on the market.
We have 10 issued and pending patents, 14 design registrations, 5 issued and pending trademarks, and a number of copyrights and trade secrets. After 5 years of R&D, we have manufactured over 12,000 fully functional first-generation pods and devices for study purposes. And our efforts resulted in a partnership announcement for a distinct product with Perrigo, a major pharmaceutical company.
The Federal Food, Drug, and Cosmetic Act (FDCA) and the Dietary Supplement Health and Education Act (DSHEA) of 1994 define the legal framework for making health claims about dietary supplements. In the United States, dietary supplement manufacturers are allowed to make certain health claims about their products under certain circumstances, but there are strict regulations that must be followed. The Company intends to comply with these regulations. Additionally, the FDA has established good manufacturing practices (GMPs) that companies must follow to help ensure the identity, purity, strength, and composition of their dietary supplements. Wellness Insight Technologies Inc partners with manufacturers and suppliers who have implemented GMPs. However, dietary supplements, including botanicals, do not require FDA approval. Kazu is not a medical device, is not intended to treat illness or disease, and does not dispense FDA approved drugs. The Kazu device does not alter the composition of dietary supplements and botanicals it dispenses. For these reasons, FDA approval of the Kazu device is not required. Should the Company see an opportunity to work with FDA approved drugs in the future, it will undertake the necessary approval process.
Why Invest
The Health and Wellness Technology of Tomorrow, Here Today
Consumer acceptance of personalized health technology is evidenced by the myriad of products that measure our bodies. But we see a huge market gap; none of these products measure and track the medicines and supplements we put into our bodies. Our initial launch will focus on CBD and melatonin in the DTC channel, but we see endless future applications including vitamins, prescription drugs, psychedelics, aromatherapy, and more. In the long term, we envision Kazu setting a new standard for dosing across natural medicines, supplements, and regulated pharmaceuticals. With half a decade of R&D and a standout team of highly experienced leaders and advisors, we are positioned to connect people to their own wellness like never before.
ABOUT
HEADQUARTERS
1210 S. Bascom Ave., STE 122
San Jose, CA 95128
WEBSITE
View Site
Kazu brings health and wellness into the future with an AI-enabled, handheld interactive device that dispenses personalized doses of medicines and supplements to achieve better results. The platform includes pods (consumables) and a connected mobile app. With thousands of first-gen units already built and production tooling complete, we are ready to move toward commercialization. The Kazu product is not yet available on the market.
TEAM
Ramon Alarcon
Founder and CEO
Rick Conrey
Director of Software Development (Part-Time)
Dennis Rasmussen
Principal Mechanical Engineer
Chris Myles
Senior Systems Engineer (Part-Time)
Adam Hoffman, PhD
Electrical Engineer (Consultant)
Amjad Huda
Consulting Financial Advisor
Keith Emmons, M.D., MPH
Advisor, Healthcare + Research
Steven Brown, PhD
Advisor, Science + Safety
Todd Manley
Director
Anna Pond, MPA
Advisor, Research Funding
William True, PhD
Advisor, Regulatory
TERMS
Kazu by Wellness Insight Technologies, Inc.
Overview
INTEREST RATE
0%
AMOUNT RAISED
$13,817.25
VALUATION CAP
$16.04M
Breakdown
MIN INVESTMENT
$200
DISCOUNT RATE
15.0%
CONVERSION TRIGGER
$3,000,000
OFFERING TYPE
Simple Agreement for Future Equity
TYPE OF EQUITY
Class B Common Stock
Company | : | Wellness Insight Technologies, Inc. |
Corporate Address | : | 1210 S. Bascom Ave., STE 122, San Jose, CA 95128 |
Offering Minimum | : | $10,000.00 |
Offering Maximum | : | $1,235,000.00 |
Minimum Investment Amount(per investor) | : | $200.00 |
Terms
Offering Type | : | Simple Agreement for Future Equity |
Type of Equity Converted Into | : | Class B Common Stock |
Conversion Trigger | : | $3,000,000.00 |
Maturity Date | : | Two years from the final closing |
Valuation Cap | : | $16,035,886.35 |
Discount Rate | : | 15.0% |
Annual Interest Rate | : | 0% |
What is Simple Agreement for Future Equity?
A Simple Agreement for Future Equity offers you the right to receive Class B Common Stock in Wellness Insight Technologies, Inc.. The amount of Class B Common Stock you will receive in the future will be determined at the next equity round in which the Company raises at least $3,000,000.00 in a qualified equity financing. The highest conversion price per security is set based on a $16,035,886.35 Valuation Cap or if less, then you will receive a 15.0% discount on the price the new investors are paying. You will receive no interest on your investment. When the maturity date is reached, if the note has not converted then you are entitled to receive Class B Common Stock equal to your investment and interest back at a price per security determined by dividing the Valuation Cap by the aggregate number of outstanding equity securities of the Company as of immediately prior (on a fully diluted basis).
Voting Proxy for Underlying Security of the CrowdFunding SAFE Sold in this Offering
As a condition to the purchase of this instrument, upon the issuance of shares of the Crowdfunding Stock (the “Securities”), the Investor agrees that the appointment of the Chief Executive Officer of the Company (the “CEO”), or his or her successor, is appointed as the Investor’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Investor, (i) vote all Securities, at any time and from time, on any matter for which approval of the holders of the Company’s stock is sought or upon which such holders are otherwise entitled to vote or consent (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Investor pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Investor is an individual, will survive the death, incompetency and disability of the Investor and, so long as the Investor is an entity, will survive the merger or reorganization of the Investor or any other entity holding the Securities. However, the proxy will terminate upon the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock. The provisions of this Section 3 shall survive the termination or expiration of this instrument in accordance with its term.
Investment Incentives*
Time-Based Perks:
Friends and Family (first 96 hours)
30% lifetime discount on Kazu pods, lifetime free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt
Super Early Bird (within the first week)
20% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt
Early Bird Bonus (within the first 2 weeks)
10% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, first access to purchase a Kazu device, and 1 Kazu T-shirt
Volume-Based Perks:
Nourishment ($500+)
First access to purchase a Kazu device, and 1 Kazu T-shirt!
Wellness ($1000+)
10% lifetime discount on Kazu pods, first access to purchase a Kazu device, and 1 Kazu T-shirt!
Rejuvenation ($2,500+)
20% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt!
Radiance ($5,000+)
30% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt
Harmony ($10,000+)
40% lifetime discount on Kazu pods, lifetime free subscription to Premium app features, an invitation to participate in beta-group for new feature releases, 1 Founder’s Series Kazu device, and 1 Kazu T-shirt
Nirvana ($25,000+)
50% lifetime discount on Kazu pods, lifetime free subscription to Premium app features, an invitation to participate in beta-group for new feature releases, 1 Founder’s Series Kazu device, 1 Kazu T-shirt, and an annual call with the CEO
*Physical perks may only be shipped to destinations within the United States.
*T-shirts and CEO calls available when the offering is fully completed.
*Pods and devices available upon market introduction.
*Discounts on pods are for personal use only. Discounts apply only to purchases made through the Company’s e-commerce site, do not apply to group/bulk purchases, do not apply to any third-party products that may be sold via the Company’s e-commerce site, and are not transferable.
*Premium subscription app features will be released after the initial release of the app and are not yet available. Subscriptions begin upon the release of paid subscription features.
*Beta-test participants must be willing to provide helpful feedback. Persons or entities with conflicts of interest with the Company may be excluded from participation.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. All perks occur when the offering is completed.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.
NEW UPDATES
03.21.23
US Patent office allows 2nd Kazu patent
On March 15, the US Patent and Trademark office allowed patent application 16/520,148. Entitled “System for Analyzing and Controlling Consumable Media Dosing Information,” the patent is a milestone achievement, placing us at the forefront of personalized dosing technology. The patent includes the ability to remotely control doses and to provide dose recommendations through machine learning. Additional US and international patents based on this invention have been filed, and if granted, will expand our IP protection into major markets abroad.
If you haven’t done so yet, invest today at www.startengine.com/offering/kazu-wellness !
Thanks!
Ramon Alarcon, CEO
ALL UPDATES
03.16.23
Kazu smashes the status quo
Hi everyone!
I’d like to highlight how Kazu stacks up against our competition - the status quo. There’s no comparison. Existing solutions have been around for decades, well before we entered the digital age. The “modern” medicine dropper, for example, was literally invented in 1957. And none of these solutions offer the ability to precisely personalize doses, automatically track consumption, and analyze outcomes. It’s 2023 for heavens sake! Let’s bring the consumption of medicines and supplements into the modern age. What are we waiting for?
If you haven’t done it yet, please invest in our campaign today www.startengine.com/offering/kazu-wellness !
Thanks!
Ramon Alarcon, CEO
03.10.23
Learn how Kazu makes money
Hi everyone!
I thought it would be good to take the opportunity to highlight how we make money. Kazu is a complete system with opportunities to monetize various elements across the platform. The base of the business is the device and consumable pods. Users will have a smart-subscription option where they can automatically receive new pods based on how full their current ones are, similar to how printer ink subscriptions work. And like most consumable businesses, the pods will be our higher margin products. As our users grow to love the platform, we plan to introduce premium features on a subscription basis, providing additional revenue opportunities.
If you haven’t done it yet, invest today. Time is running out to get the early bird incentives!
www.startengine.com/offering/kazu-wellness
Thanks!
Ramon Alarcon, CEO
03.07.23
What should we add next to our lineup?
Hi everyone!
Kazu will launch with CBD and melatonin.
CBN and CBG are growing in popularity and we are already testing internally with those ingredients.
We love getting input from our investor community. What should we add to our lineup next?
If you haven’t done it yet, please invest in our campaign!
Thanks!
Ramon Alarcon, CEO
03.07.23
Now taking reservations for Kazu on our website
Hi Everyone!
We are excited to announce that our website is now taking reservations for Kazu!
If you missed out on the super early bird reward, there’s still time to get first access to purchase a Kazu when it launches by investing today. Act now to also get a 10% lifetime discount on pods and more!
Thanks!
Ramon Alarcon, CEO
REWARDS
$500
Nourishment
First access to purchase a Kazu device, and 1 Kazu T-shirt!
$1,000
Wellness
10% lifetime discount on Kazu pods, first access to purchase a Kazu device, and 1 Kazu T-shirt!
$2,500
Rejuvenation
20% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt!
$5,000
Radiance
30% lifetime discount on Kazu pods, 1-year free subscription to Premium app features, 1 Kazu device, and 1 Kazu T-shirt
$10,000
Harmony
40% lifetime discount on Kazu pods, lifetime free subscription to Premium app features, invitation to participate in beta-group for new feature releases, 1 Founder’s Series Kazu device, and 1 Kazu T-shirt
$25,000
Nirvana
50% lifetime discount on Kazu pods, lifetime free subscription to Premium app features, invitation to participate in beta-group for new feature releases, 1 Founder’s Series Kazu device, 1 Kazu T-shirt, and an annual call with the CEO
JOIN THE DISCUSSION
0/2500
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
